Sanford Cancer Center

Sioux Falls, South Dakota 57105-1521

8 studies enrolling now · 28 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Advanced or Metastatic Solid Tumors, Advanced/Metastatic Solid Tumors, Bladder Cancer, Breast Cancer, Breast Neoplasms, Cancer, Cancer of Head and Neck, Cancer of the Head and Neck, Carcinoma, Non-Small Cell Lung, Carcinoma, Squamous Cell

Studies at this site

• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors — Recruiting now
• The Minimalist Trial-2 — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer — Recruiting now
• A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer — Recruiting now
• A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS). — Recruiting now
• A Study of Sigvotatug Vedotin in Advanced Solid Tumors — Recruiting now
• Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer — Recruiting now
• A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors — Running, not enrolling
• Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients — Running, not enrolling
• First-in-Human Study of TAK-280 in Participants With Solid Tumors — Stopped early
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
• A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors — Stopped early
• CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer — Running, not enrolling
• A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer — Stopped early
• NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy — Running, not enrolling
• A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Running, not enrolling
• Phase 2 Study of DKN-01 in Colorectal Cancer — Completed
• QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer — Stopped early
• Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) — Completed
• Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 — Stopped early
• A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• A Study of SGN-CD228A in Advanced Solid Tumors — Stopped early
• A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer — Stopped early
• Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208) — Stopped early
• Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors — Completed
• A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors — Stopped early